Yvonne Kienast

3.5k total citations · 2 hit papers
22 papers, 2.2k citations indexed

About

Yvonne Kienast is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Yvonne Kienast has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Yvonne Kienast's work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Glioma Diagnosis and Treatment (4 papers). Yvonne Kienast is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Glioma Diagnosis and Treatment (4 papers). Yvonne Kienast collaborates with scholars based in Germany, United States and Switzerland. Yvonne Kienast's co-authors include Frank Winkler, Louisa von Baumgarten, Jochen Herms, Martin Fuhrmann, Roland Goldbrunner, Wolfgang E. F. Klinkert, Michele De Palma, Martina Schmittnaegel, Chia-Huey Ooi and Damya Laoui and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Yvonne Kienast

22 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-time imaging reveals the single steps of brain metastasis formation

2009 825 citations Yvonne Kienast, Louisa von Baumgarten et al. Nature Medicine profile →
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade

2017 444 citations Martina Schmittnaegel, Yvonne Kienast et al. profile →

Peers

Countries citing papers authored by Yvonne Kienast

Since Specialization

Citations

This map shows the geographic impact of Yvonne Kienast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Kienast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Kienast more than expected).

Fields of papers citing papers by Yvonne Kienast

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne Kienast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Kienast. The network helps show where Yvonne Kienast may publish in the future.

Co-authorship network of co-authors of Yvonne Kienast

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Kienast. A scholar is included among the top collaborators of Yvonne Kienast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Kienast. Yvonne Kienast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metagenomics indicate that public health risk may be higher from flooding following dry versus rainy periods 2022 ·Environmental Microbiology Reports ·Minjae Kim, Yvonne Kienast, Janet K. Hatt, Amy Kirby, Konstantinos T. Konstantinidis	5
2	Norovirus Seroprevalence among Adults in the United States: Analysis of NHANES Serum Specimens from 1999–2000 and 2003–2004 2020 ·Viruses ·Amy Kirby, Yvonne Kienast, Wanzhe Zhu, Jerusha Barton, (unknown), (unknown), Jan Vinjé, Christine L. Moe	4
3	Snow Mountain Virus recovery by synthetic human histo-blood group antigens is heavily influenced by matrix effects 2020 ·Scientific Reports ·Amy Kirby, Yvonne Kienast, (unknown), Molly Steele, (unknown), Dandan Liu, (unknown), Amrita Das, Suri S. Iyer, Christine L. Moe	2
4	Ethical dimensions of neglected tropical disease programming 2020 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·David G. Addiss, Yvonne Kienast, James V. Lavery	4
5	Differential Effects of Ang-2/VEGF-A Inhibiting Antibodies in Combination with Radio- or Chemotherapy in Glioma 2019 ·Cancers ·Gergely Solecki, Matthias Osswald, D. Weber, (unknown), Miriam Ratliff, Hans‐Joachim Müller, Oliver Krieter, Yvonne Kienast, Wolfgang Wick, Frank Winkler	7
6	Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity 2018 ·The Journal of Experimental Medicine ·Sabine Hoves, Chia-Huey Ooi, (unknown), Hadassah Sade, Stefan Bissinger, Martina Schmittnaegel, Oliver Ast, Anna Maria Giusti, Katharina Wartha, Valeria Runza, Wei Xu, Yvonne Kienast, Michael A. Cannarile, Hyam I. Levitsky, Solange Romagnoli, Michele De Palma, Dominik Rüttinger, Carola H. Ries	153
7	Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma 2017 ·Journal of Hepatology ·Chaobo Hu, Weiping Li, Feng Tian, Kai Jiang, Xiaoting Liu, Jin Cen, (unknown), Zhixin Qiu, Yvonne Kienast, (unknown), Haibin Zhang, Yuan Ji, Junhao Hu, Lijian Hui	57
8	Impact of selective anti‐BMP9 treatment on tumor cells and tumor angiogenesis 2016 ·Molecular Oncology ·Verena Brand, Christian H.K. Lehmann, Christian Umkehrer, Stefan Bissinger, (unknown), (unknown), (unknown), Ute Jucknischke, Alexander K. Haas, Sebastian Breuer, Fabian Birzele, Tomáš Raček, Marco Reis, Erica Lorenzon, Frank Herting, Michael Stürzl, Stefan Lorenz, Yvonne Kienast	10
9	Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy 2016 ·JCI Insight ·Jiha Kim, Pedro Corrêa de Sampaio, (unknown), Qian Peng, Kurt W. Evans, Hikaru Sugimoto, Mihai Gagea, Yvonne Kienast, (unknown), Rafael Malagoli Rocha, Hans Petter Eikesdal, Per Eystein Lønning, Funda Meric‐Bernstam, Valerie S. LeBleu	24
10	Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains 2015 ·Journal of Biological Chemistry ·Yvonne Kienast, Ute Jucknischke, Stefan Scheiblich, (unknown), (unknown), Alexander K. Haas, Christian H.K. Lehmann, Verena Brand, Dirk Bernicke, Konrad Honold, Stefan Lorenz	31
11	Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy 2013 ·Clinical Cancer Research ·Yvonne Kienast, Christian Klein, Werner Scheuer, (unknown), Erica Lorenzon, Dirk Bernicke, Frank Herting, Sidney Yu, (unknown), Laurent Martarello, Christian Gassner, (unknown), (unknown), Hellmut G. Augustin, Markus Thomas	143
12	A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors 2013 ·PLoS ONE ·Markus Thomas, Yvonne Kienast, Werner Scheuer, Monika Bähner, Klaus Kaluza, Christian Gassner, Frank Herting, Ulrich Brinkmann, Stefan Seeber, (unknown), Martin Welschof, Stefan Ries, K. Michael Weidner, Jörg T. Regula, Christian Klein	50
13	Optical needle endoscope for safe and precise stereotactically guided biopsy sampling in neurosurgery 2012 ·Optics Express ·Werner Göbel, (unknown), Yvonne Kienast, Ann Johansson, (unknown), Adrian Rühm, Sabina Eigenbrod, Stefan Fischer, Marcus Goetz, Friedrich-Wilhelm Kreth, André Ehrhardt, Herbert Stepp, (unknown), Jochen Herms	28
14	Abstract 2319: Dual inhibition of Ang-2 and VEGF via a novel human bispecific bivalent IgG1 CrossMAb shows potent anti-angiogenic, antitumoral, and antimetastatic efficacy and leads to a reduced side effect profile compared to single therapies 2012 ·Cancer Research ·Markus Thomas, Yvonne Kienast, Werner Scheuer, Erica Lorenzon, Frank Herting, Marielle Odin, Wolfgang Schaefer, Jörg T. Regula, Kay‐Gunnar Stubenrauch, Christian Klein	2
15	Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells 2011 ·Clinical Cancer Research ·Louisa von Baumgarten, (unknown), (unknown), Yvonne Kienast, Stefan Grau, Steffen Burgold, Jochen Herms, Frank Winkler	137
16	TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma 2010 ·Cell Death and Differentiation ·Virginia Egea, Louisa von Baumgarten, (unknown), Benedikt Berninger, Tanja Popp, Peter Neth, Roland Goldbrunner, Yvonne Kienast, Frank Winkler, Marianne Jochum, Christian Ries	70
17	Therapy and prophylaxis of brain metastases 2010 ·Expert Review of Anticancer Therapy ·Yvonne Kienast, Frank Winkler	33
18	Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis 2009 ·Glia ·Frank Winkler, Yvonne Kienast, Martin Fuhrmann, Louisa von Baumgarten, Steffen Burgold, Gerda Mitteregger, Hans A. Kretzschmar, Jochen Herms	168
19	Real-time imaging reveals the single steps of brain metastasis formation breakdown → 2009 ·Nature Medicine ·Yvonne Kienast, Louisa von Baumgarten, Martin Fuhrmann, Wolfgang E. F. Klinkert, Roland Goldbrunner, Jochen Herms, Frank Winkler	825
20	Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro 2006 ·BMC Cardiovascular Disorders ·Oleg Tolmachov, Yuling Ma, Michael Themis, Pravina M. Patel, (unknown), Kenneth T. MacLeod, Nina D. Ullrich, Yvonne Kienast, Charles Coutelle, Nicholas S. Peters	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact